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Abstract
Objective There are indications that type D personality and
depression are associated in patients treated with percuta-
neous coronary intervention (PCI). However, at present it
is unclear whether this relationship holds in the long term.
This study’s aim was to investigate the association between
type D personality at 6 months post-PCI (baseline), and de-
pression at 10-year follow-up. A secondary aim was to test
the association between type D personality at baseline and
anxiety at 10-year follow-up.
Methods A cohort of surviving consecutive patients (N =
534) who underwent PCI between October 2001 and Octo-
ber 2002. Patients completed the type D personality scale
(DS14) measuring type D personality at baseline, and the
Hospital Anxiety and Depression Scale (HADS) measuring
anxiety and depression at baseline and at 10 years post-PCI.
Results At baseline, the prevalence of type D personal-
ity was 25 % (135/534). Type D personality patients were
more often depressed (42 %) than non-type D personality
patients (9 %). Response rate of anxiety and depression
questionnaires at 10 years was 75 %. At 10-year follow-up,
31 % of type D personality patients were depressed versus
13 % of non-type D personality patients. After adjustments,
baseline type D personality remained independently asso-
ciated with depression at 10 years (OR = 3.69; 95 % CI
[1.89–7.19]). Type D showed a similar association with
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anxiety at 10 years, albeit somewhat lower (OR = 2.72;
95 % CI [1.31–5.63]).
Conclusions PCI patients with type D personality had
a 3.69-fold increased risk for depression and a 2.72-fold
increased risk for anxiety at 10 years of follow-up.
Keywords Depression · Anxiety · Coronary artery
disease · PCI · Type D personality
Introduction
Since the introduction of drug-eluting stents in the early
2000 s, prognosis has been improved significantly [1].
Therefore, secondary outcomes such as quality of life,
safety, depression and anxiety have become more impor-
tant.
Personality may play a role in the mental and physical
health of coronary artery disease (CAD) patients. Patients
with distressed personality (type D) showed negative affec-
tivity and social inhibition [2] and this was associated with
depression and anxiety [3, 4]. Moreover type D personal-
ity corresponded with adverse cardiac outcomes in patients
with CAD. One study compared high negativity/high inhi-
bition patients (type D) with high negativity/low inhibition
patients. Type D personality showed an increased risk in
major adverse cardiac events such as myocardial infarction
(MI), percutaneous coronary intervention (PCI), and coro-
nary artery bypass graft (CABG) at 15 months post-PCI
while high negativity/low inhibition did not [5]. These are
concerning findings since the prevalence of type D person-
ality is around 20–50 % and therefore type D is a factor that
should not be ignored [6].
The prevalence of depression in patients with coronary
artery disease (CAD) ranges from 25 % to 50 % [7–11].
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Exclusion 1:
309 no response at baseline
283 died
Exclusion 2:
111 had no 10-year follow-up
174 had no HADS response or 
incomplete HADS
Included:
534 patients with 10-year follow-up 
and response DS-14 and HADS
1411 patients who underwent PCI 
during 2001-2002
Fig. 1 Flowchart of patient inclusion
Studies have shown an increased mortality in patients with
depression. The study populations consisted of patients
with CAD, CABG, PCI and heart failure [12–16]. De-
pressed patients may have an increased risk of adverse
events after PCI [16]. Depressed patients have a poorer
prognosis with higher cardiac mortality compared with non-
depressed patients [17].
Because recognition of depression might be too late,
since the patient is then already depressed, early recognition
of type D personality could improve treatment outcomes
and lead to a better prognosis, since type D was associated
with an increased risk for MI, PCI, CABG and adverse
prognosis [5, 18]. With timely identification of type D
personality, the risks of this personality style for (cardiac)
health outcomes can be communicated with the patients
and, if necessary, adequate referral to a mental health pro-
fessional with expertise in the field can take place.
The aim of the present study was to investigate whether
type D personality, assessed at baseline, is associated with
depression, not only at one year post-PCI, but also at
10 years after PCI. Anxiety at 10-year follow-up was also
investigated as a secondary objective.
Methods
Participants and procedures
This was a consecutive prospective cohort registry of pa-
tients who underwent PCI between October 2001 and Oc-
tober 2002 (n = 1411). At 6 months post-PCI (referred to
as baseline in the remainder of this paper) patients were
asked to fill in psychological questionnaires to assess anxi-
ety, depression (using the Hospital Anxiety and Depression
Scale; HADS), and type D personality (using the Type D
Scale-14, DS14). Assessment of 6 months post-PCI was
chosen to ascertain a stable medical and mental condition.
At 10 years, survival status was assessed using the civil
registry. All surviving patients were sent a letter including
the HADS questionnaire.
Of the 1411 eligible patients who underwent PCI, 309
patients did not return the questionnaire at baseline. Of the
remaining 1102 patients, 283 died. Of the 819 remaining
patients, 534 responded to the HADS questionnaire (Fig. 1).
This study was not subject to the Dutch Medical Re-
search Involving Human Subjects Act. Therefore, approval
from the local research ethics committee to conduct this
prospective follow-up study was not required at the time of
enrolment. All patients consented to participation in this
study by returning the questionnaire. However, in 2013 we
received approval from our local medical ethics committee
for this on-going PCI Registry (MEC-2013-262). The study
was conducted according to the Helsinki Declaration [19].
Sociodemographic and clinical characteristics
Sociodemographic characteristics included gender and
age. Clinical characteristics included multi-vessel disease
(multi-vessel disease versus single-vessel disease/no vessel
disease), cardiac history (i. e., previous MI, CABG surgery,
or PCI), indication for PCI (angina pectoris, unstable angina
pectoris, or MI), cardiac risk factors (i. e., hypertension,
hypercholesterolaemia, diabetes, family history of CAD
and self-reported smoking). Information on clinical vari-
ables was prospectively collected at the time of the index-
PCI/baseline and recorded in the institutional database.
Type D personality
The DS14 was used to assess type D personality. The DS14
uses two subscales with seven items each. One scale is used
to assess negative affectivity and the other one is used to
assess social inhibition. Negative affectivity is a term that
covers certain feelings such as ‘I often feel unhappy’ and ‘I
often find myself worrying about something’. While social
inhibition covers social discomfort and problems with so-
cial interactions [20]. Items can be scored from 0 (false) to
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Tab. 1 Baseline characteristics according to type D and non-type D
Type D Non-Type D P
No. of patients 135 (25 %) 399 (75 %)
Male 96 (71 %) 305 (77 %) 0.24
Age± SD 59± 9.7 60± 9.6 0.19
Clinical characteristics
Multivessel disease 64 (47 %) 185 (46 %) 0.83
Old MI 50 (37 %) 145 (37 %) 0.98
Old PCI 17 (13 %) 75 (19 %) 0.10
Old CABG 12 (9 %) 32 (8 %) 0.75
Risk factors
Hypertension 53 (39 %) 138 (35 %) 0.33
Family history 50 (37 %) 121 (30 %) 0.15
Current smoker 57 (42 %) 123 (31 %) 0.02
Diabetes mellitus 18 (13 %) 38 (10 %) 0.21
Cholesterol 111 (82 %) 324 (81 %) 0.79
Indication for PCI 0.29
Stable angina 59 (44 %) 199 (50 %)
Unstable angina 54 (40 %) 130 (33 %)
Acute myocardial infarction 22 (16 %) 70 (18 %)
Medication
Aspirin 130 (96 %) 389 (98 %) 0.36
Calcium antagonist 72 (53 %) 189 (48 %) 0.24
Beta blocker 90 (67 %) 273 (69 %) 0.68
Oral nitrates 17 (13 %) 54 (14 %) 0.77
Diuretic 21 (16 %) 51 (13 %) 0.42
ACE inhibitor 33 (24 %) 128 (32 %) 0.09
Statin 108 (80 %) 312 (78 %) 0.69
Psychological characteristics
Anxiety 73 (54 %) 61(15 %) < 0.001
Depression 57 (42 %) 35 (9 %) < 0.001
4 (true). Type D personality was identified if both subscales
scored ≥ 10 points [21].
Anxiety and depression
Anxiety and depression was assessed by completing the
Dutch version of the HADS. The HADS consists of two
subscales. One subscale is used to measure anxiety and
the other is used to measure depression. Each subscale has
seven items which can be scored from 0 to 3. A cut-off
score of ≥ 8 was used to determine depression and anxiety
[22].
Statistical analysis
Patients were grouped according to type D and non-type D
personality. Differences between groups were analysed us-
ing the Chi-square test for nominal variables and the Stu-
dent’s t-test for continuous variables. A multivariable logis-
tic regression model was used to investigate the association
between type D personality and depression and anxiety,
respectively. Also adjustments were made for all base-
line characteristics. Additionally, adjustments were made
for baseline anxiety and depression. Interactions between
type D personality, and anxiety and depression were inves-
tigated.
The outcomes were reported with odds ratio (OR) and
their corresponding 95 % confidence interval (CI). All re-
sults were based on two-tailed tests and a p < 0.05 was used
to indicate statistical significance. Data analysis has been
done with SPSS version 21.
Results
Baseline characteristics
The prevalence of baseline type D personality was 25 %
(135/534). The prevalence of depression at baseline was
42 % (57/135) in type D personality patients versus 9 %
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Tab. 2 Univariable and multivariable analysis: association between baseline type D and depression and anxiety at 10 years
OR[95%CI]
Depression
Univariable type D personality 3.08[1.93–4.92]
Adjusted for baseline characteristics type D personalitya 3.70[2.23–6.13]
Adjusted for baseline characteristics + baseline depression type D personality 3.69[1.89–7.19]
Anxiety
Univariable type D personality 3.43[2.22–5.30]
Adjusted for baseline characteristics type D personalitya 3.52[2.24–5.53]
Adjusted for baseline characteristics + baseline anxiety type D personality 2.72[1.31–5.63]
aExcluding baseline depression/baseline anxiety
(35/399) in non-type D personality patients. Anxiety was
also more prevalent in the type D personality patients. Fur-
thermore, most baseline characteristics did not differ be-
tween the two groups, except for the finding that type D
personality patients were more often smokers (Tab. 1).
Association between baseline type D personality and
depression at 10 years
The prevalence of depression at 10 years of follow-up was
31 % (42/135) in type D personality patients versus 13 %
(51/399) in non-type D personality patients. Univariable
analysis showed a strong association between type D per-
sonality and depression at 10 years (OR = 3.08; 95 % CI
[1.93–4.92]) (Tab. 2). After adjusting for baseline charac-
teristics, type D personality showed an even stronger asso-
ciation with depression (OR = 3.70; 95 % CI [2.23–6.13]).
In the third model, type D was adjusted for baseline char-
acteristics and baseline depression. The OR remained the
same but the CI widened (OR = 3.69; 95 % CI [1.89–7.19]).
Depression at baseline was found to be a strong cofactor
and therefore an interaction variable was made. The interac-
tion between type D personality and depression at baseline
proved to be significant and, therefore, the interaction was
added in the multivariable model. The analysis showed that
the association between type D personality and depression
was stable in all models (Tab. 2).
Association between baseline type D personality and
anxiety at 10 years
The prevalence of anxiety at 10-year follow-up was
40 % (54/135) in type D personality patients versus 16 %
(65/399) in non-type D personality patients. In univariable
analysis type D personality was associated with anxi-
ety at 10-year follow-up (OR = 3.43; 95 % CI [2.22–5.30])
(Tab. 2). After adjusting for baseline characteristics, type D
personality remained associated with anxiety (OR = 3.52;
95 % [2.24–5.53]). In the third model, type D was adjusted
for baseline characteristics and baseline anxiety. The OR
between type D and anxiety at 10 years was still significant
(OR = 2.72; 95 % CI [1.31–5.63]). Anxiety at baseline was
found to be a strong cofactor and therefore an interaction
variable was made. The interaction between type D per-
sonality and anxiety proved to be significant and, therefore,
the interaction was added in the multivariable model.
Discussion
Type D personality early after PCI was associated with
a 3.69-fold increased risk for depression and 2.72-fold in-
creased risk for anxiety 10 years after PCI. Earlier, our
research group reported an association between type D per-
sonality and depressive symptoms at one year [3, 23]. This
present study showed that this association sustained at least
up to 10 years after PCI. Two other studies outside of our
research group also showed an association between type D
personality and depression with a follow-up period of 1 year
[24, 25].
One study, however, found no relation between type D
personality and the development of major depression or mi-
nor depression in 250 patients who had an acute coronary
syndrome [26]. Major or minor depression in this study was
measured by the DSM-IV. This raises questions whether
type D personality is a personality trait or not. The limita-
tion of that study was its small sample size. Furthermore,
the HADS used in our study has been proven to be a valid
questionnaire for symptom severity and case recognition of
anxiety and depression disorder [22].
The patients selected for this study were a good represen-
tation of PCI patients. It should be noted that our patients
were Dutch-speaking. The question can be raised whether
type D personality generalises across regions and cultures.
However, type D personality was shown to be generalised
across cultures in a recent study [6]. Together with the
findings of this study and the previous ones, it shows that
type D personality is universal. Though the cross-cultural
analysis of the study only extends to European and English-
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speaking countries, it may also extend to Asian countries
[27, 28].
Despite all the evident results of the effect of type D
personality, there still is a discussion concerning the valid-
ity of type D personality. Bacon et al. suggested in their
commentary that while studies show that type D personal-
ity is independently associated with depression in different
populations, the cut-off point of 10 was criticised [29].
The same statistical models were used to test associations
between type D personality at baseline and depression and
anxiety, respectively, at 10-year follow-up. Type D person-
ality was proved to be not only associated with an increased
risk for depression at 10 years of follow-up, but also with an
increased risk for anxiety. Previously we reported the asso-
ciation between type D personality at baseline and anxiety
at one year in PCI patients [4, 30]. Now we have extended
our findings regarding this association to up to 10 years of
follow-up.
Unfortunately, systematic data regarding the use of psy-
chotherapy or antidepressant or antianxiety medication in
our patient sample were not available. Therefore, it is un-
known to what extent these factors may have influenced
the present findings. Future research should also take these
treatments into account.
At baseline we achieved a response rate of 79 %, which
is quite reasonable. During 10 years a number of patients
died or were lost to follow-up and for the remaining patients
we achieved a very similar result with a response rate of
75 %. While we are of the opinion that the numbers are rea-
sonable, we should acknowledge that this could introduce
selection bias.
In summary, type D personality is a predictive tool to
identify patients who have an elevated risk for depression
and anxiety, 10 years after PCI. Type D personality has
been shown to be a stable personality taxonomy [4]. So,
presumably, a patient with type D personality will have
this personality for many years or for the rest of his or
her life, making it more reliable than the HADS, which is
a state measure fluctuating across time and situation. The
importance of these results lies in the clinical use of type D
personality in identifying PCI patients with a high risk for
depression and anxiety.
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